Primary Site >> Colorectal Cancer
Gene >> GCG
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells. PMID: 2882565 |
Ref: Central role of the adipocyte in the metabolic syndrome. PMID: 11217141 |
Ref: Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect. PMID: 15256284 |
Ref: DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells. PMID: 16908079 |
Ref: Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts. PMID: 17920582 Ref: Why diabetes patients are more prone to the development of colon cancer? PMID: 18456417 Ref: Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells. PMID: 18829546 |
Ref: Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. PMID: 19224585 Ref: The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study. PMID: 19538729 |
Ref: Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. PMID: 20110284 |
Ref: The "cryptic" mechanism of action of glucagon-like peptide-2. PMID: 21527727 Ref: Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. PMID: 21771884 Ref: Does glucagon like peptide-2 receptor expression have any effect on the development of human colorectal cancer? PMID: 21948569 |
Ref: The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors. PMID: 22426235 Ref: Genome-wide screening of genes regulated by DNA methylation in colon cancer development. PMID: 23049694 |
Ref: Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy? PMID: 23583681 |
Ref: Should GLP-1 receptor agonists be used with caution in high risk population for colorectal cancer? PMID: 24424394 |
Ref: Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats. PMID: 26536615 |
Ref: The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice. PMID: 26573958 |
Ref: Exendin-4 does not modify growth or apoptosis of human colon cancer cells. PMID: 28318339 Ref: Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway. PMID: 28363795 Ref: Phytochemical and Biological Evaluations of Arum hygrophilum Boiss. (Araceae). PMID: 28539721 Ref: Functional polymorphisms in the promoter region of miR-17-92 cluster are associated with a decreased risk of colorectal cancer. PMID: 29137282 |
Ref: Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes. PMID: 29283894 Ref: Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population PMID: 29580042 Ref: Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence. PMID: 29659199 |